18h
Aicuris Receives FDA Priority Review for Pritelivir NDA and Presents New Phase 3 Data at ESCMID 2026
The U.S. Food and Drug Administration has granted Priority Review for Aicuris’ New Drug Application for pritelivir, a novel helicase primase ...
Additional Phase 1b data for ABI-5366, including results from monthly dosing cohort, selected for oral presentation – – Phase 1b data from ABI-1179 accepted for late-breaker poster presentation – ...
Assembly Biosciences Inc. research and ratings by Barron's. View ASMB revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
TotalEnergies flags earnings boost from strong trading and oil price spike TotalEnergies expects a significant increase in first-quarter earnings thanks to a strong trading performance and higher oil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results